we sought to find a characteristic that might help us CRF is thought to be a key link between the behavioral identify, a priori, CRF-responsive neurons. The majority and physiological effects of stress and drugs of abuse of neurons in the VTA are dopaminergic and express I h , (Shaham et al., 2000) . The dopaminergic neurons of the a hyperpolarization-activated inward current. This curventral tegmental area (VTA) and their widespread prorent is commonly used to identify putative dopamine jections to areas such as the nucleus accumbens, preneurons (e.g., Bonci and Malenka, 1999). However, it has previously been shown that these neurons can be 
. This suggests that the in the VTA using in situ hybridization techniques, CRF-R2 mRNA has been reported to be absent (Van Pett et that CRF might somehow interact with the CRF-BP to Discussion signal through CRF-R2 and potentiate NMDAR-mediated EPSCs.
In the present study, we demonstrate that CRF induces a potentiation of NMDAR-mediated EPSCs in a subset It has been suggested that the Urocortin family of CRF-like peptides may be the endogenous ligands for of VTA neurons containing a large I h . Our experiments indicate that this potentiation is mediated by the R2 CRF-R2 (Vaughan et al., 1995) . Urocortin binds CRF-R2 and the CRF-BP with higher affinity than CRF, while it subtype of CRF receptors and requires the activation of PLC and PKC. In addition, we present evidence sugbinds CRF-R1 with a slightly lower affinity than CRF-R2; in contrast, Urocortin II binds selectively to CRF-R2, gesting that the CRF-BP might be necessary for CRFinduced potentiation of NMDAR-mediated EPSCs. showing low affinity for both CRF-R1 and the CRF-BP (Reyes et al., 2001 ). In addition to this preferential bindThe potentiation of NMDAR-mediated EPSCs is concentration dependent, with both 1 M CRF and 100 ing to CRF-R2, Urocortin and Urocortin II both exhibit some anatomical overlap with CRF-R2. Given our finding nM but not 10nM, producing significant increases in NMDAR-mediated EPSCs. Although it is possible that that CRF needs to interact with both CRF-R2 and CRF-BP to potentiate NMDARs, we expected Urocortin, but 1 M CRF might be saturating (Lovenberg et al., 1995), it is unlikely that the effect of CRF observed in the present not Urocortin II, to mimic CRF. Accordingly, we observed potentiation of NMDAR-mediated EPSCs following apstudy was due to nonspecific actions of CRF. First, the CRF-induced potentiation of NMDAR currents was plication of Urocortin (1 M for 8 min; Figure 3C ) and no potentiation of NMDAR-mediated EPSCs following blocked by selective concentrations of a CRF-R2 antagonist. Second, it is likely that the concentration of CRF application of Urocortin II (1 M for 8 min; Figure 3D ). These results further suggest that the CRF-BP is importhat reaches receptors in a brain slice preparation is reduced due to problems with diffusion as well as degratant for the ability of CRF (or CRF-like ligands) to potentiate NMDAR function. Based on these results we propose dation of CRF by endogenous enzymes (Ritchie et al., 2003) . Finally, endogenous ligands such as glutamate the model illustrated in Figures 3E and 3F . We hypothesize that when CRF is not bound to the CRF-BP it does are released at concentrations considerably higher than receptor EC50 values derived from cell lines (Clements not activate CRF-R2 ( Figure 3E ). However, when CRF is bound to the CRF-BP it can activate CRF-R2 and the et al., 1992). Consequently, we believe that it is likely that applying CRF at a concentration of 1 M mimics PLC pathway to potentiate NMDAR-mediated EPSCs in VTA neurons ( Figure 3F) . physiologically relevant actions of CRF (except that en-dogenous CRF would be released in such concentraspecifically through the PLC-PKC pathway when bound to CRF-R2. tions in a highly localized fashion).
The current study also demonstrates that the effect Activation of NMDARs in the VTA plays a key role in the switch from regular firing to burst firing in dopamine of CRF on NMDAR-mediated EPSCs in the VTA was likely mediated by CRF-R2. This is supported by the neurons ( 
